McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow, despite recent price increases and solid growth prospects in oncology and GLP-1 medications ...

Healthcare distribution and services specialist McKesson (NYSE:MCK) reported mixed financial results for fiscal 2025's third quarter on Wednesday, Feb. 5. McKesson beat earnings expectations with ...

Please stand by. Welcome to McKesson's third quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the call over ...

Deep-pocketed investors have adopted a bearish approach towards McKesson MCK, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

(RTTNews) - McKesson (MCK) signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC, a provider of general ophthalmology and retina management services ...